Cross-tolerance between morphine- and bombesin-induced inhibition of intestinal transit in rats.
Intracerebroventricular (i.c.v.) injection of either morphine or bombesin to rats inhibits intestinal transit of an intraduodenally administered radiochromium marker. In this work, we show that tolerance develops to this effect of bombesin after i.c.v. infusion of the peptide (0.5 micrograms/h for 4 days via an s.c. implanted Alzet 2001 osmotic minipump). Tolerance also develops to the inhibition of intestinal transit associated with i.c.v. morphine after s.c. injections of morphine. Bombesin-induced delay of transit is not attenuated by naltrexone (10 mg/kg, s.c.), a standard narcotic antagonist. Nevertheless, two-way cross-tolerance develops between bombesin and morphine in this system. This is a surprising result since both bombesin and morphine are believed to act on different receptors and cause opposite effects on intestinal motility in rats.
D000818:Animals; D001839:Bombesin / Q000494:pharmacology*; D004361:Drug Tolerance; D005769:Gastrointestinal Motility / Q000187:drug effects*; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D009271:Naltrexone / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D009270:Naloxone; D009271:Naltrexone; D009020:Morphine; D001839:Bombesin